ÍSÍtalo Sousa

Ítalo Sousa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ítalo Sousa has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long‐Term Follow‐Up of Inducible Bundle Branch Reentrant Ventricular Tachycardia in Patients Without Structural Heart Disease: Beyond the Electrophysiology Laboratory

    by Muhieddine Omar Chokr, Haroldo Heitor Ribeiro Filho, Roberto Alvarez Coello, Rodrigo Melo Kulchetscki, Lucas Moura, Francisco Darrieux, Denise T. Hachul, Luciana Sacilotto, Tan C. Wu, Pedro M. Vandoni, et al.

    Background: Bundle branch reentrant ventricular tachycardia (BBR‐VT) is a rare form of VT occurring in patients with structural heart disease (SHD). Rarely, it can also occur in the absence of SHD. Understanding its clinical and electrophysiologic (EP) properties and outcomes post‐catheter ablation (CA) is crucial.Objective: We present a series of patients with bundle branch reentrant ventricular tachycardia (BBR‐VT) and structurally normal hearts, comparing their clinical and electrophysiological characteristics, as well as long‐term outcomes, with those of patients with the classic form of BBR‐VT, in whom the arrhythmia was induced in the presence of ventricular dysfunction.Methods: All cases of BBR‐VT diagnosed during electrophysiological (EP) studies in our lab were evaluated. Clinical characteristics and EP findings were described.Results: Sixteen patients (12/16 male; mean age 50 ± 21 years) with BBR‐VT were studied from 2009 to 2020, with a mean follow‐up of 70 ± 16 months. Notably, nearly half (7/16; 43%) had no structural heart disease (SHD). Among these, three had myotonic dystrophy, two had SCN5A mutations, one had ajmaline‐induced BBR‐VT, and one had idiopathic BBR‐VT. BBR‐VT was induced with a mean cycle length of 322 ± 22 ms and was well tolerated in 10/16 patients. Right bundle branch catheter ablation was performed using an 8 mm solid‐tip catheter, leading to an HV interval increase from 72 ± 9 ms to 100 ± 23 ms. One patient developed total AV block. Postprocedure, device implantation was required in 13/16 patients (dual‐chamber pacemaker: 10; ICD: 3). Notably, no patient experienced VT recurrence during follow‐up.Conclusion: BBR‐VT is traditionally associated with dilated cardiomyopathy, but it can also occur in structurally normal hearts. Myotonic dystrophy and SCN5A mutations may underlie some cases. Right bundle branch ablation is an effective treatment, though device implantation is usually required.


  • Open Access

    Long-Term Follow-Up of inducible Bundle Branch Reentrant Ventricular Tachycardia: Beyond the Electrophysiology Laboratory

    by Muhieddine Chokr, Haroldo R. Filho, Roberto Alvarez Coello, Rodrigo Melo Kulchetscki, Lucas Moura, Francisco Darrieux, Denise Hachul, Luciana Sacilotto, Tan Wu, Pedro M. Vandoni, et al.

    Background: Bundle branch reentrant ventricular tachycardia (BBR-VT) is a rare form of VT occurring in patients with structural heart disease (SHD). Rarely, it can also occur in the absence of SHD. Understanding its clinical and electrophysiologic (EP) properties and outcomes post-catheter ablation (CA) is crucial. Objective: We describe a case series of patients diagnosed with BBR-VT regarding clinical and EP characteristics, as well as long term follow-up after CA. Methods: All cases of BBR-VT that were diagnosed during EP study in our lab were evaluated. Clinical characteristics and EP findings were described. Results: Sixteen patients (12/16 male; mean age 50±21) with BBR-VT were studied from 2009-2020, with a mean follow-up of 70±16 months. Notably, nearly half (7; 43%) had no SHD. Patients without SHD (7; 43%) had Steinert dystrophy (3/7), SCN5A mutations (2/7), ajmaline-induced (1/7) or idiopathic BBR-VT (1/7). We suggest an algorithm for the evaluation of patients with BBR-VT without SHD. The induced BBR VT had a mean cycle length of 322±22 ms, was well tolerated in 10/16. A RBB CA was performed with an 8 mm solid-tip catheter. The HV interval increased from 72±9 to 100±23 ms. One patient developed total AV block. After the procedure, either a dual chamber pacemaker (10/16) or an ICD (3/16) was implanted. No patient presented VT recurrence. Conclusion: Although traditionally associated with patients with dilated cardiomyopathy, our study demonstrates that nearly half of BBR-VT cases occur in patients with structurally normal hearts. Once these patients are identified, Steinert’s disease should be considered as a potential underlying condition. . In the absence of ocular abnormalities, genetic testing may be warranted, particularly in the attempt to identify SCN5A mutations. Right bundle branch ablation is effective in most cases; however, device implantation is often required to ensure optimal long-term management.

  • Comparison between cryotherapy and radiofrequency energy sources for parahisian accessory pathway percutaneous ablation

    by Italo Bruno dos Santos Sousa, Muhieddine Omar Chokr, Sissy Lara Melo, Cristiano Faria Pisani, Carina Abigail Hardy, Lucas Goyanna de Moura, Luciana Sacilotto, Tan Chen Wu, Francisco Carlos Costa Darrieux, Mauricio Ibrahim Scanavacca

    Background Catheter ablation of parahisian accessory pathways (PHAP) are challenging due to their proximity to the normal conduction system. Retrospective studies suggest that cryoablation has a better safety profile but a higher recurrence rate when compared to radiofrequency ablation (RFCA). The objective of this study was to compare the results of parahisian AP ablation performed by electrophysiologists with experience in both technologies. Methods Prospective single-center, non-blinded and 1:1 model was used. Patients included had parahisian AP confirmed by an electrophysiological study and referred for radiofrequency or cryotherapy ablation according to current guidelines, under fluoroscopic guidance. No electroanatomic mapping was used. Results A total of 30 patients (mean age of 25±9.4 years; 90% male) were enrolled between Oct/2018 to Feb/2020. Acute success rate between RFCA and CRYO were similar (93% vs. 87%, p = 0.54). A nonsignificant reduction in short-term recurrence rate for RFCA (14% vs. 30%, p = 0.3) and mechanical trauma (6% vs. 20%; p = 0.28) was observed. Long-term recurrence rate and event-free survival time were similar in both groups after 1-year follow-up (p = 0.286). No persistent complete AV block or conduction disturbance was also observed. Conclusion Considering the limitation of a small sample size and the lack of use of electroanatomic mapping for RFCA, the efficacy and safety profile of parahisian AP ablation with RFCA was not different from CRYO, when performed by experienced electrophysiologists. No cases of permanent complete AV block were reported with either energy modalities.


  • Open Access

    Transatrial management of inadvertent puncture of the posterior wall during transseptal access for atrial fibrillation ablation -- Case report

    by Muhieddine Chokr, Ítalo Sousa, Tamer El Andere, Luiz Fernando de Gouvea Filho, Mauricio Ibrahim Scanavacca

    Transseptal puncture for atrial fibrillation ablation is a safe and common procedure, however, complications, such as cardiac tamponade, are possibly fatal if not recognized and treated. Our goal is to report a case in which management of an inadvertent puncture of the posterior wall of the left atrium was accomplished using an unusual technique, followed by successful pulmonary vein isolation, and without the need of subsequent subxiphoid puncture.

  • Pulmonary Embolism in Patients with Covid-19 in Direct Oral Anticoagulant

    by Fabio Augusto De Luca, Guilherme Arruda, Vinicius Esteves, André Feldman, Ítalo Bruno dos Santos Sousa, José Célio Vieira Brandão, Raquel Muarrek Garcia, Olga Ferreira de Souza

    Introduction The global pandemic caused by the new coronavirus (COVID-19) has been promoting major challenges and unprecedented clinical decisions in the medical scenario. Currently, according to the World Health Organization, the disease affects over 185 countries, with over 12 million people infected and nearly 500 thousand deaths. Among the most serious manifestations of the syndrome, the high prevalence of thromboembolic events, up to 31% of the patients hospitalized in intensive care units, according to an international series, calls attention.– Different [...] Introduction The global pandemic caused by the new coronavirus (COVID-19) has been promoting major challenges and unprecedented clinical decisions in the medical scenario. Currently, according to the World Health Organization, the disease affects over 185 countries, with over 12 million people infected and nearly 500 thousand deaths. Among the most serious manifestations of the syndrome, the high prevalence of thromboembolic events, up to 31% of the patients hospitalized in intensive care units, according to an international series, calls attention.– Different